This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Tonen Corporation, International Reagent Corporation, Tokyo Metropolitan Institute of Medical Science. Active years: 1995-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saitama, JP (1995)
- Iruma-gun, JP (1998 - 1999)
Company Filing History:
4 out of 141 
1 out of 1 
1 out of 56 Years Active: 1995-1999
Title: Shintaro Yagi: Innovator in Hepatitis Research
Introduction
Shintaro Yagi is a notable inventor based in Iruma-gun, Japan. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of hepatitis. With a total of 4 patents to his name, Yagi's work has had a profound impact on immunological research.
Latest Patents
Yagi's latest patents include groundbreaking inventions such as the immunoassay of non-A, non-B hepatitis virus-related antigens. This invention focuses on a monoclonal antibody that specifically binds to an antigenic determinant site on the core structural protein from Non-A, Non-B hepatitis virus (NANBV). The patent also covers a hybridoma cell line capable of producing this monoclonal antibody, a process for its preparation, and a test kit for use in immunoassays. The preferred monoclonal antibodies identified in this patent are 5E3, 5F11, 515S, or 1080S. These antibodies can specifically recognize the NANBV core structural protein in sera from patients, making them invaluable for the definitive diagnosis of Non-A, Non-B hepatitis.
Another significant patent involves antigenic peptides for growing hepatitis C virus. This invention relates to NS4-related antigenic peptides that can react specifically with antibodies directed against Group I and Group II of hepatitis C virus (HCV). The patent also includes a kit for identifying HCV Groups I or II, which comprises these peptides in separate sections. This innovation allows for the specific detection of HCV Groups I or II and aids in the early treatment of HCV Group II-infected patients.
Career Highlights
Throughout his career, Shintaro Yagi has worked with esteemed organizations such as Tonen Corporation and the Tokyo Metropolitan Institute of Medical Science. His work in these institutions has furthered his research and development in the field of hepatitis.
Collaborations
Yagi has collaborated with notable colleagues, including Noboru Maki and Masanori Suzuki. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Shintaro Yagi's contributions to hepatitis research through his innovative patents have significantly enhanced the field of medical diagnostics. His work continues to influence the development of effective treatments and diagnostic tools for
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile